Evidence map›Paper›PMID 18411289›Full record

ArticleInfection and immunity2008

Role for myosin II in regulating positioning of Salmonella-containing vacuoles and intracellular replication.

Julie A Wasylnka, Malina A Bakowski, Jason Szeto, Maikke B Ohlson, William S Trimble, Samuel I Miller, John H Brumell

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. SIK2 orchestrates actin-dependent host response uponProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. The Interplay of Host Lysosomes and Intracellular Pathogens.Frontiers in cellular and infection microbiology · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Maintenance of vacuole integrity by bacterial pathogens.Current opinion in microbiology · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julie A WasylnkaCell Biology Program, Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada.
Malina A Bakowski
Jason Szeto
Maikke B Ohlson
William S Trimble
Samuel I Miller
John H Brumell
Hospital for Sick Children · CAUniversity of Washington · US

Funding

SALMONELLA PATHOGENICITY ISLAND 2 EFFECTOR PROTEINSR01AI048683 · NIAID · UNIVERSITY OF WASHINGTON · PI MILLER, SAMUEL I · 2001 to 2015
$5.1M
NIAID NIH HHS R01 AI048683
6 · The paper itself

Abstract

Salmonella enterica serovar Typhimurium grows within host cells in a permissive compartment termed the Salmonella-containing vacuole (SCV). These bacteria use two distinct type III secretion systems (T3SS) to deliver virulence proteins (effectors) into cells. Effectors secreted by the Salmonella pathogenicity island 1 (SPI-1)-encoded T3SS mediate invasion and early SCV maturation steps, while those secreted by the SPI-2 T3SS affect the SCV at later stages postinfection. Some SPI-2 effectors modulate microtubule motor activity on the SCV. Here, we show that the actin-based motor myosin II also affects SCV dynamics during infection. Following invasion, myosin II is required for SCV positioning near the nucleus of host cells. Later, myosin II counteracts the activities of the SPI-2 effectors PipB2 and SseJ to maintain SCV positioning and stability, respectively. Myosin II activity was required for maximal bacterial growth in macrophages. Rho kinase activity was required for SCV positioning. The effector SopB, a known activator of Rho GTPases, was found to be required for SCV positioning, and transfection of cells with SopB was sufficient to induce myosin II phosphorylation. These studies reveal a novel role for myosin II in controlling SCV dynamics during infection and suggest that SopB activates myosin II.

Indexed as

AnimalsBacterial ProteinsCell DivisionCell NucleusGene Expression RegulationHeLa CellsHeterocyclic Compounds, 4 or More RingsHumansMacrophagesMiceMyosin Type IIrho-Associated KinasesSalmonella typhimuriumVacuolesBacterial ProteinsblebbistatinHeterocyclic Compounds, 4 or More RingsMyosin Type IIrho-Associated KinasesSopB protein, Salmonella

Identifiers

PMID18411289
PMCPMC2423101
OpenAlexW2109199551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.